National Competence Centres
Personalised Medicine: From Translational Research into BiomedicalApplications
PERMED: T2BA (TN02000109)
PERMED: T2BA Consortium meeting
PERMED: T2BA Scientific board meeting (NCC Council)
Place: IMTM, Hněvotínská 1333/5, Olomouc
Date: June 12-13, 2025
PROGRAM June 12th
11:30-12:15LUNCH – bufet SNACK 4D (Faculty of Medicine – in front of IMTM building)
ROOM 1.09
12:15-12:30 – INTRODUCTORY INFORMATION – Hajdúch
12:30-13:00 – Hajdúch (DP 14) Management and strategic sub-project (DP 11) Biomarkers and molecular diagnostics for personalized medicine
13:00-13:30 – Vyklický/Kudová (DP 6) - Study of functional and behavioralconsequences of disease-associated mutations in the NMDA receptor and potential rescue pharmacology
13:30-14:00 – Vrábel (DP 5) Development of chimeric antigen receptor modifiedimmune cells for cancer immunotherapy
14:00-14:15 BREAK
14:15-14:45 – Maletínská (DP 8) Interplay between anorexigenic and orexigenicpeptides in Alzheimer’s-like pathology
14:45-15:15 – Nencka (DP 9) Novel (multi)targeted ligands of nuclear receptors for thetherapy of the metabolic diseases
15:15-15:45 – Brynda (Maloy Řezáčová) (DP4) Theranostic applications of cancerspecific carbonic anhydrases
15:45-16:15 – Petřík (DP 10) Targeted molecular imaging of infection and cancerdisorders
16:30-17:00 – BOARD MEETING (onsite and/or online) / (Decristoforo, Fusek, Hajdúch, Hauser, Martásek, Normanton, Perlík)
ROOM 2.48
13:30-14:30 – ADMINISTRATION MEETING (onsite and/or online)
Project/financial managers of consortium
--------------------------------------------------------------------------------------------------------------------------
PROGRAM June 13th
ROOM 1.09
09:00-9:30 – Prát (DP 12) Casein kinase inhibitors for treatment of human cancers
9:30-10:00 – Macek (DP 2) Artificial intelligence, telemedicine and machine learning system for clinical applications
10:00-10:30 – Brož (DP 1) Development of informatic solutions enabling digitalization, interpretation and management of human genome data in clinical practice
10:30-10:45 – BREAK
10:45-11:15 – Martásek/Jakubek (DP 13) Biomedical prospecting of a life pigment: metabolic basis of inherited heme
11:15-11:45 – Janeba (DP7) Purine nucleoside phosphorylase inhibitors for treatmentof T-cell leukemia
11:45-12:00 – Tichý/Hajdúch (DP 3) Novel nucleoside analogues as potent anticancerdrugs
12:00-13:00 – LUNCH – bufet SNACK 4D (Faculty of Medicine – in front of IMTM building)
National Centers of Competence
Personalised Medicine: From Translational Research into Biomedical Applications
PERMED: T2BA (TN02000109)